Gender Differences in Diagnosis, Prevention, and Treatment of Cardiotoxicity in Cardio-Oncology

Shawn Simek, Brian Lue, Anjali Rao, Goutham Ravipati, Srilakshmi Vallabhaneni, Kathleen W Zhang, Vlad G. Zaha, Alvin Chandra

Research output: Contribution to journalReview articlepeer-review

Abstract

Gender differences exist throughout the medical field and significant progress has been made in understanding the effects of gender in many aspects of healthcare. The field of cardio-oncology is diverse and dynamic with new oncologic and cardiovascular therapies approved each year; however, there is limited knowledge regarding the effects of gender within cardio-oncology, particularly the impact of gender on cardiotoxicities. The relationship between gender and cardio-oncology is unique in that gender likely affects not only the biological underpinnings of cancer susceptibility, but also the response to both oncologic and cardiovascular therapies. Furthermore, gender has significant socioeconomic and psychosocial implications which may impact cancer and cardiovascular risk factor profiles, cancer susceptibility, and the delivery of healthcare. In this review, we summarize the effects of gender on susceptibility of cancer, response to cardiovascular and cancer therapies, delivery of healthcare, and highlight the need for further gender specific studies regarding the cardiovascular effects of current and future oncological treatments.

Original languageEnglish (US)
Article number5167
JournalJournal of Clinical Medicine
Volume11
Issue number17
DOIs
StatePublished - Sep 2022

Keywords

  • cancer
  • cardio-oncology
  • cardiotoxicity
  • cardiovascular disease
  • gender
  • sex

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Gender Differences in Diagnosis, Prevention, and Treatment of Cardiotoxicity in Cardio-Oncology'. Together they form a unique fingerprint.

Cite this